$3 Million Additional Funding for Medicalgorithmics from BioFund
Medicalgorithmics and the company’s dominant shareholder, BioFund Capital Management LLC, have signed an agreement to establish a loan line of up to $3 million. The agreement confirms the company’s comfort in implementing its 2023-2026 strategy and expands its development opportunities. Currently, Medicalgorithmics does not plan to use the line, financing its operations with its own funds and operating cash flows.